Shares of Biogen Inc. BIIB slipped 1.40% to $138.37 Friday, on what proved to be an all-around rough trading session for the ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

The company and Sanofi just posted positive results from a pivotal ADEPT Phase 2/3 trial. While we’re not seeing any specific news, BIIB has become a value play. Keep your portfolio well-protected ...

Biogen (BIIB) announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the May 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

Even with the cheaper entry price, we're cautious about Biogen. Here are three reasons why BIIB doesn't excite us and a stock we'd rather own. Founded in 1978 in Switzerland as one of the first ...

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics ...

Commonwealth Equity Services LLC trimmed its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 7.2% in the ...

Get Our Latest Stock Report on Biogen Biogen Stock Down 1.7 % Shares of BIIB stock opened at $139.16 on Wednesday. Biogen Inc. has a twelve month low of $128.51 and a twelve month high of $238.00 ...

Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.